Baxion
Screening
Tags
Alerts
Theme
Fennec Pharmaceuticals Inc.
FENC
·
NASDAQ
·
$9.89
Share Price as of 11/2
·
$283M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/13/26
10-Q
Q1 ended 03/31/26
05/14/26
10-K
FY 2025
03/27/26
10-Q
Q3 ended 09/30/25
11/13/25
10-Q
Q2 ended 06/30/25
08/14/25
Disclosures
Filter
8-K
Current report
09/17/26
8-K
Current report
06/10/26
8-K
Current report
05/22/26
8-K
Current report
05/18/26
8-K
Current report
04/28/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
06/11/26
S-8
Registration of securities for employees
03/05/26
424B5
Prospectus supplement
11/18/25
S-8
Registration of securities for employees
11/18/25
424B5
Prospectus supplement
11/17/25
Proxies
Filter
DEF 14A
Definitive proxy
04/28/26
DEF 14A
Definitive proxy
04/25/25
DEF 14A
Definitive proxy
05/13/24
DEF 14A
Definitive proxy
04/28/23
DEF 14A
Definitive proxy
05/02/22
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
10/19/26
Form 4
Insider transaction
10/13/26
Form 4
Insider transaction
10/13/26
Form 4
Insider transaction
10/13/26
Form 4
Insider transaction
10/13/26
Other
Filter
EFFECT
Request for effectiveness
12/15/23
CORRESP
Correspondence with the SEC
12/13/23
UPLOAD
Letter from the SEC
11/28/23
EFFECT
Request for effectiveness
12/12/22
CORRESP
Correspondence with the SEC
12/08/22
Latest Filings
Filter
8-K
Current report
09/17/26
10-Q
Q2 ended 06/30/26
08/13/26
S-8
Registration of securities for employees
06/11/26
8-K
Current report
06/10/26
8-K
Current report
05/22/26
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
10/19/26
Form 4
Insider transaction
10/13/26
Form 4
Insider transaction
10/13/26
Form 4
Insider transaction
10/13/26
Form 4
Insider transaction
10/13/26